This content is restricted to site members. If you are an existing user, please log in. New users may register below.
Valeant announces U.S. launch of SILIQâ„¢ (brodalumab) injection
Valeant Pharmaceuticals International, Inc. announced the launch of SILIQ™ (brodalumab) Injection during the Summer American Academy of Dermatology (AAD) meeting taking place in New York